Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
The licensed oral, live-attenuated bacterial vaccine for typhoid fever, Salmonella enterica serovar Typhi strain Ty21a, has also been utilized as a vaccine delivery platform for expression of diverse foreign antigens that stimulate protection against shigellosis, anthrax, plague, or human papilloma...
Main Authors: | Madushini N Dharmasena, Catherine M Feuille, Carly Elizabeth C Starke, Arvind A Bhagwat, Scott Stibitz, Dennis J Kopecko |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5046385?pdf=render |
Similar Items
-
The human immune response to oral vaccination with live-attenuated Salmonella Typhi (Ty21a)
by: Pennington, S. H.
Published: (2017) -
Konstruktion eines Balanced lethal Systems für Salmonella typhi Ty21a
by: Diessner, Ernst Joachim
Published: (2009) -
Optimierung eines Balanced Lethal Systems für Salmonella Typhi Ty21a
by: Gesser, Martin Benedikt Ambros
Published: (2011) -
Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Salmonella Typhi Antigen Presentation
by: Mark E. Rudolph, et al.
Published: (2019-03-01) -
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis
by: B. Kim Lee Sim, et al.
Published: (2017-06-01)